Ting Ma

75 University Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Comprehensive Metabolic Profiling of Resigratinib, a Novel FGFR Inhibitor, Using Integrated LC-MS/MS and LC-Orbitrap-HRMS.

Comprehensive Metabolic Profiling of Resigratinib, a Novel FGFR Inhibitor, Using Integrated LC-MS/MS and LC-Orbitrap-HRMS.

Journal: Rapid communications in mass spectrometry : RCM

Published: August 31, 2025

Ailanthone targets mitophagy-loaded SIRT4 to facilitate the deacetylation of HIF1α, triggering oxidative stress for gastric carcinoma treatment.

Ailanthone targets mitophagy-loaded SIRT4 to facilitate the deacetylation of HIF1α, triggering oxidative stress for gastric carcinoma treatment.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 22, 2025

Epigenetic roles of lysine-specific demethylase 1 (LSD1) in cancer metabolism.

Epigenetic roles of lysine-specific demethylase 1 (LSD1) in cancer metabolism.

Journal: Drug discovery today

Published: April 02, 2025

Design, Synthesis, and Mechanism Study of Novel BMX Inhibitors Based on the Core of 1,3,5-Triazin-2-Amine for the Treatment of Gastric Carcinoma.

Design, Synthesis, and Mechanism Study of Novel BMX Inhibitors Based on the Core of 1,3,5-Triazin-2-Amine for the Treatment of Gastric Carcinoma.

Journal: Journal of medicinal chemistry

Published: February 15, 2025

Nucleolin inhibits α-synuclein to attenuate aconitine's neurotoxicity.

Nucleolin inhibits α-synuclein to attenuate aconitine's neurotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 05, 2025

Repetitive transcranial magnetic stimulation as add-on the rapyin persistent postural-perceptual dizziness.

Repetitive transcranial magnetic stimulation as add-on the rapyin persistent postural-perceptual dizziness.

Journal: IBRO neuroscience reports

Published: August 10, 2024

LSD1 is a promising target to treat cancers by modulating cell stemness.

LSD1 is a promising target to treat cancers by modulating cell stemness.

Journal: Biochemical pharmacology

Published: June 11, 2024

Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.

Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.

Journal: Bioorganic chemistry

Published: December 12, 2023

Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.

Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 11, 2023

Strategies that regulate LSD1 for novel therapeutics.

Strategies that regulate LSD1 for novel therapeutics.

Journal: Acta pharmaceutica Sinica. B

Published: August 19, 2023

The relationship between tumor metabolism and 5-fluorouracil resistance.

The relationship between tumor metabolism and 5-fluorouracil resistance.

Journal: Biochemical pharmacology

Published: August 19, 2023

The emerging potential role of p62 in cancer treatment by regulating metabolism.

The emerging potential role of p62 in cancer treatment by regulating metabolism.

Journal: Trends in endocrinology and metabolism: TEM

Published: April 02, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026